Animal Weight Is an Important Variable for Reliable Cuprizone-Induced Demyelination.


Journal

Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 11 01 2019
accepted: 22 03 2019
pubmed: 3 4 2019
medline: 18 12 2019
entrez: 3 4 2019
Statut: ppublish

Résumé

An elegant model to study mechanisms operant during oligodendrocyte degeneration and subsequent demyelination is the cuprizone model. In that model, mice are intoxicated with the copper chelation agent cuprizone which results in early oligodendrocyte stress, oligodendrocyte apoptosis, and, finally, demyelination. Here, we systematically investigated to what extent the animals' weight at the beginning of the cuprizone intoxication period is critical for the reproducibility of the cuprizone-induced pathology. We can demonstrate that a negative correlation exists between the two variables "extent of cuprizone-induced demyelination" and "starting weight." Demyelination and microglia activation were more severe in low weight compared to heavy weight mice. These findings are highly relevant for the experimental design using the cuprizone model.

Identifiants

pubmed: 30937629
doi: 10.1007/s12031-019-01312-0
pii: 10.1007/s12031-019-01312-0
doi:

Substances chimiques

Cuprizone 5N16U7E0AO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

522-528

Subventions

Organisme : Deutsche Forschungsgemeinschaft (DE)
ID : KI 1469/8-1

Références

Neuropathol Appl Neurobiol. 2000 Feb;26(1):2-10
pubmed: 10736062
Neurochem Res. 2007 Feb;32(2):279-92
pubmed: 17063394
Brain. 2008 Jul;131(Pt 7):1722-35
pubmed: 18515320
Brain Pathol. 2009 Jul;19(3):467-79
pubmed: 19016742
Glia. 2009 Jun;57(8):807-14
pubmed: 19031445
Neurobiol Dis. 2010 Feb;37(2):362-9
pubmed: 19853662
Nature. 2012 Apr 29;485(7399):517-21
pubmed: 22622581
Glia. 2012 Oct;60(10):1468-80
pubmed: 22689449
J Mol Neurosci. 2013 Jan;49(1):80-8
pubmed: 23054589
Brain Pathol. 2013 Jul;23(4):462-75
pubmed: 23311751
Immunology. 1990 May;70(1):6-10
pubmed: 2354862
Neuroscience. 2013 Aug 15;245:166-78
pubmed: 23597832
J Mol Neurosci. 2013 Oct;51(2):567-72
pubmed: 23666824
Cell Mol Neurobiol. 2013 Nov;33(8):1087-98
pubmed: 23979168
Glia. 2014 Oct;62(10):1629-44
pubmed: 24890315
J Immunol. 2015 Apr 1;194(7):3400-13
pubmed: 25725102
Acta Neuropathol. 2015 Aug;130(2):263-77
pubmed: 26087903
Biochim Biophys Acta. 2016 Mar;1862(3):506-10
pubmed: 26432481
Brain Pathol. 2017 Mar;27(2):123-137
pubmed: 27792289
J Mol Neurosci. 2017 Apr;61(4):617-624
pubmed: 28238065
J Neurol Sci. 1988 Apr;84(2-3):223-37
pubmed: 2837540
Glia. 2018 Sep;66(9):1999-2012
pubmed: 29761559
Mol Neurobiol. 2019 Feb;56(2):1109-1123
pubmed: 29873041
Anat Cell Biol. 2018 Jun;51(2):119-127
pubmed: 29984057
Glia. 2019 Feb;67(2):263-276
pubmed: 30511355
Metab Brain Dis. 2019 Apr;34(2):681-685
pubmed: 30607821
Cells. 2019 Jan 07;8(1):null
pubmed: 30621015
Cells. 2019 Jan 28;8(2):null
pubmed: 30696113
Schriftenr Neurol. 1983;25:1-135
pubmed: 6605578
Lab Invest. 1981 Dec;45(6):534-46
pubmed: 7321526
Nat Med. 1999 Feb;5(2):170-5
pubmed: 9930864

Auteurs

Patrizia Leopold (P)

Institute of Anatomy, Rostock University Medical Center, 18057, Rostock, Germany.
Department of Anatomy II, Ludwig-Maximilians-University of Munich, 80336, Munich, Germany.

Christoph Schmitz (C)

Department of Anatomy II, Ludwig-Maximilians-University of Munich, 80336, Munich, Germany.

Markus Kipp (M)

Institute of Anatomy, Rostock University Medical Center, 18057, Rostock, Germany. Markus.kipp@med.uni-rostock.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH